This study will investigate how food and age effect the way the body handles the AZD5069 drug given as a oral dose
Study identifier:D3550C00010
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Phase I, two-part study to investigate the effects of food on the PK, safety and tolerability of a single oral dose of AZD5069 (120 mg) in healthy adult volunteers (Part A) and to compare the PK of AZD5069 in adult and elderly healthy volunteers (Part B)
Medical condition
Chronic Obstructive Pulmonary Disease
Phase
Phase 1
Healthy volunteers
Yes
Study drug
AZD5069
Sex
All
Actual Enrollment
24
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Feb 2010
Primary Completion Date: 01 Jul 2010
Study Completion Date: 01 Jul 2010
Study design
Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science
Verification:
Verified 01 Jun 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
Quintiles
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 AZD5069 following a 10-hour fast | Drug: AZD5069 120mg single oral dose |
| Experimental: 2 AZD5069 30 minutes after the start of a high fat meal | Drug: AZD5069 120mg single oral dose |
Contacts
Investigators
Principal Investigator
Darren Wilbraham
Quintiles Drug Research Unit at Guy's Hospital
